O2M Technologies is a device company developing oxygen imaging instruments for in vitro and in vivo measurements in tissue samples and in small animals. We use patented technology to generate 3D oxygen maps. Tissue oxygen maps obtained using our technology can be used to develop enhanced therapies. The examples include but not limited to: develop better artificial cell replacement devices, assist drug development, and probe vitality of artificial tissue grafts pre- and post-implantation, guide cancer radiation treatment, assess immunotherapy and chemotherapy outcomes.

O2M is supported with SBIR awards from NIH and NSF and a SRA grant from JDRF: